Clinical Trial Update: Interaction of Epanova on Warfarin Pharmacokinetic and Anticoagulant Activity and Comparison of the Effects of Epanova and Lovaza on Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) After Low-fat Meals [Phase 1]

View source ↗

Summary

Phase 1 study evaluating warfarin pharmacokinetics and anticoagulant activity with Epanova, and comparing EPA/DHA effects of Epanova versus Lovaza after low-fat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia

Drugs mentioned

• Epanova (icosapent ethyl)
• LOVAZA (OMEGA-3-ACID ETHYL ESTERS)

Snippet

Sponsor: AstraZeneca | Conditions: Hypertriglyceridemia | Phase 1 | Status: COMPLETED